← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

▼ SELL 10b5-1 Plan

$ Value

$8K

Shares

40

Price

$201

Filed

Apr 2

Insider

Name

KOZARICH JOHN W

Title

CIK

0001223000

Roles

Director

Transaction Details

Transaction Date

2026-04-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

42,534

Footnotes

The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 07, 2025, in accordance with Rule 10b5-1. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $199.6900 to $200.3150. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $201.0050 to $201.4650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.0750 to $202.6400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $202.8550 to $203.6550. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $204.0050 to $204.5400. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0002001011-26-000038

Form Type

4

Issuer CIK

0000886163

KOZARICH JOHN W's History

Date Ticker Type Value
2026-04-01 LGND $29K
2026-04-01 LGND $8K
2026-04-01 LGND $16K
2026-04-01 LGND $9K
2026-04-01 LGND $32K
2025-12-01 LGND $18K
2025-12-01 LGND $35K
2025-12-01 LGND $9K
2025-12-01 LGND $785
2025-12-01 LGND $18K

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $86K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01